News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Rhinomed.
RELATED STOCKHEAD STORIES
News
ASX Small Cap Lunch Wrap: Who’s trying not to blink today?
News
10 at 10: These ASX stocks are doing the best amidst the rough markets this morning
Health & Biotech
Check up: Rhinomed (ASX:RNO) soars with NSW COVID contract, and genetic testing fails to impress
Health & Biotech
ScoPo’s Powerplays: ‘Lots of money on sidelines waiting for pullbacks’, as all eyes are on earnings next week
News
Weekly ASX small cap wrap: Market maintains upward momentum
News
Closing Bell: ASX cruises to another record high ahead of US inflation data
News
ASX Small Cap Lunch Wrap: Who’s ready for a US$1 trillion infrastructure bill this morning?
Health & Biotech
ASX health stocks: Rhinomed rockets 80% after securing first government purchase for COVID-19 Rhinoswabs
Health & Biotech
Rhinomed positioned for growth in billion-dollar nasal tech market, as share price rockets 40pc in a month
Experts
ScoPo’s powerplays: Healthcare hit by ‘Covid exit trade’, but opportunities remain
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
Health Kick Podcast: Investors smell success in Rhinomed’s flu and coronavirus nasal swab technology
News
September Winners Column: Battery metals sentiment has come roaring back
Experts
ScoPo’s health powerplays: ‘We’re buying any pullbacks’
Health & Biotech
Weed Week: Good news from the TGA, but Australia’s CBD industry still lags the global pack
News
Closing Bell: Today’s biggest small cap movers on the ASX
Health & Biotech
